Cardiac Rhythm Management Devices Market - Top Companies and Manufacturers

Companies Dominating the cardiac rhythm management devices Landscape

The cardiac rhythm management devices market is dominated by key market players who are gaining traction in the market by adopting several strategies including merger and acquisitions.

Vitatron Holding B.V.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Medtronic
Biotronik
Abbott
ABIOMED
Stryker Corporation
Amiitalia.
© BPL Medical Technologies
OSYPKA MEDICAL
MicroPort Scientific Corporation

Browse Key Market Insights with Data Illustration:

Cardiac Rhythm Management Devices Market Size Forecasts 2037

In the News

Medtronic’s PulseSelect Pulsed Field Ablation (PFA) System was approved by the US Food and Drug Administration (FDA) to treat paroxysmal and persistent atrial fibrillation (AF), according to an announcement made by the firm. Following the PulseSelect PFA system's November European CE (Conformité Européenne) Mark, this is the first PFA technology to be approved by the FDA.
Abbott announced that the US Food and Drug Administration has approved the AssertIQTM insertable cardiac monitor, providing physicians with a new option for diagnostic evaluation and long-term monitoring of patients who experience an irregular heartbeat. This clearance builds on Abbott's portfolio of connected medical devices that can help doctors better manage and treat their patients remotely.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cardiac rhythm management devices is estimated at USD 18.75 billion.

The cardiac rhythm management devices market size was valued at USD 17.88 billion in 2024 and is likely to cross USD 38.61 billion by 2037, registering more than 6.1% CAGR during the forecast period i.e., between 2025-2037. The aging population, which is more prone to heart-related conditions will propel the market growth.

North America industry is predicted to account for largest revenue share of 36% by 2037, influenced by well-developed healthcare infrastructure in the region

The major players in the market include Vitatron Holding B.V., Medtronic, Biotronik, Abbott, ABIOMED, Stryker Corporation, Amiitalia., © BPL Medical Technologies, OSYPKA MEDICAL, MicroPort Scientific Corporation

Cardiac Rhythm Management Devices Market - Top Companies and Manufacturers

Companies Dominating the cardiac rhythm management devices Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the cardiac rhythm management devices market?

Why is the cardiac rhythm management devices sector gaining traction in near future?

Which region accounted for the largest cardiac rhythm management devices industry share?

Who are the major cardiac rhythm management devices players?